Viewing Study NCT00250367


Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2025-12-25 @ 10:48 PM
Study NCT ID: NCT00250367
Status: COMPLETED
Last Update Posted: 2010-11-25
First Post: 2005-11-04
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.
Sponsor: Janssen Pharmaceutica N.V., Belgium
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 1997-10
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 1999-11
Completion Date Type: ACTUAL
First Submit Date: 2005-11-04
First Submit QC Date: None
Study First Post Date: 2005-11-08
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2010-11-24
Last Update Post Date: 2010-11-25
Last Update Post Date Type: ESTIMATED